Nazila Habibizad

Nazila Habibizad

Senior Vice President, Operations

Ms. Habibizad joined GBT in January 2016 as vice president, technical operations, and was promoted to senior vice president, technical operations in October 2019. Under her direction and leadership, GBT successfully executed the chemistry and manufacturing control activities supporting the NDA submission, approval and launch of Oxbryta (voxelotor) in the United States. In March 2020, she was promoted to senior vice president, operations, where she is responsible for the manufacturing, global supply chain and logistics, and quality assurance functions. Prior to GBT, she worked at Onyx Pharmaceuticals (acquired by Amgen), where she held roles of increasing responsibility, the most recent being senior director of CMC analytical. At Onyx, she played a critical role in the NDA submission, approval and global commercialization of Kyprolis®. Prior to that, she held positions at Proteolix, Johnson & Johnson and Alza Corporation. Ms. Habibizad has particular expertise in chemistry and manufacturing control (CMC) and a track record leading key activities and teams in product development from initial concept through commercialization across multiple global marketed products, including Concerta® and Invega®. She earned a B.S. in chemistry from the University of California, Berkeley.